Titan Pharmaceuticals, Inc. (TN70.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 10:18PM CEST
| Previous close | 5.92 |
| Open | 6.24 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 5.92 - 6.24 |
| 52-week range | 4.40 - 15.00 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 6.112M |
| Beta (5Y monthly) | 1.35 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 01 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireTitan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria
SOUTH SAN FRANCISCO, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that by letter dated January 24, 2024, the Company was notified by The Nasdaq Stock Market LLC that the Company has regained compliance with the minimum $1.00 bid price requirement and otherwise satisfies all applicable criteria for continued listing on The Nasdaq Capital Market. As such, the listing matter has been closed. About Titan Pharmaceutica
© 2024 Yahoo. All rights reserved.